EdgarLookup

MEDICINOVA INC — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
IWAKI YUICHI President and CEO Purchase 50,000 568,972 Mar 29, 2011
COFFEE MICHAEL DENIS CBO & Interim CFO Purchase 4,000 4,000 Mar 29, 2011
Johnson Kirk William Chief Scientific Officer Purchase 2,200 2,200 Mar 29, 2011
Kalafer Michael E Chief Medical Officer Purchase 19,586 $4.42 $86,570 31,744 Jul 28, 2009
IWAKI YUICHI Chief Executive Officer Purchase 1,800 $2.25 $4,050 643,972 Feb 2, 2009
IWAKI YUICHI Chief Executive Officer Purchase 1,650 $2.15 $3,548 640,972 Jan 23, 2009
IWAKI YUICHI Chief Executive Officer Purchase 2,200 $2.16 $4,752 637,122 Jan 16, 2009
IWAKI YUICHI Chief Executive Officer Purchase 2,000 $1.50 $3,000 631,851 Jan 15, 2009
IWAKI YUICHI Chief Executive Officer Purchase 1,300 $8.21 $10,673 627,851 Oct 4, 2007
IWAKI YUICHI Chief Executive Officer Purchase 730 $7.90 $5,767 618,581 Oct 1, 2007
IWAKI YUICHI Chief Executive Officer Disposition 49,977 $7.36 $367,831 617,851 Sep 21, 2007
Tanabe Holding America Inc. Disposition 5,000,000 $1.00 $5,000,000 5,000,000 Oct 13, 2006
IWAKI YUICHI Chief Executive Officer X 1,500,000 $0.10 $150,000 3,000,000 Aug 7, 2006
IWAKI YUICHI Acting CEO X 1,250,000 $0.10 $125,000 1,500,000 Mar 2, 2006